These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25421473)

  • 1. Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.
    Deslouches B; Steckbeck JD; Craigo JK; Doi Y; Burns JL; Montelaro RC
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1329-33. PubMed ID: 25421473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis and Burkholderia pseudomallei.
    Abdelbaqi S; Deslouches B; Steckbeck J; Montelaro R; Reed DS
    J Med Microbiol; 2016 Feb; 65(2):188-194. PubMed ID: 26673248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria.
    Di YP; Lin Q; Chen C; Montelaro RC; Doi Y; Deslouches B
    Sci Adv; 2020 May; 6(18):eaay6817. PubMed ID: 32426473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.
    Deslouches B; Steckbeck JD; Craigo JK; Doi Y; Mietzner TA; Montelaro RC
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2511-21. PubMed ID: 23507278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
    Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
    Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria.
    Deslouches B; Montelaro RC; Urish KL; Di YP
    Pharmaceutics; 2020 May; 12(6):. PubMed ID: 32486228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antimicrobial peptides on colistin-susceptible and colistin-resistant strains of Klebsiella pneumoniae and Enterobacter asburiae.
    Kádár B; Kocsis B; Kristof K; Tóth Á; Szabó D
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):501-8. PubMed ID: 26689883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.
    Conlon JM; Sonnevend A; Pál T; Vila-Farrés X
    Int J Antimicrob Agents; 2012 Apr; 39(4):317-20. PubMed ID: 22326566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
    Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
    Bragonzi A
    Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
    Personne Y; Curtis MA; Wareham DW; Waite RD
    J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.
    Deslouches B; Hasek ML; Craigo JK; Steckbeck JD; Montelaro RC
    J Med Microbiol; 2016 Jun; 65(6):554-565. PubMed ID: 27046192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37.
    Lin Q; Deslouches B; Montelaro RC; Di YP
    Int J Antimicrob Agents; 2018 Nov; 52(5):667-672. PubMed ID: 29753132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
    Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
    Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
    Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
    J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria.
    Moghadam MT; Mojtahedi A; Moghaddam MM; Fasihi-Ramandi M; Mirnejad R
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):3879-3893. PubMed ID: 35604438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.